Medyssey Co Ltd
Capital Structure and Liquidity Medyssey maintains a strong liquidity position with a current ratio of 5.66, indicating a robust ability to meet short-term obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity risk. The debt-to-equity ratio of 0.06 suggests a conservative capital structure with minimal leverage. ### Profitability and Returns The company's return on equity (ROE) of 8.83% and return on assets (ROA) of 7.38% indicate solid profitability relative to its equity and asset base. These metrics suggest that Medyssey is effectively utilizing its capital to generate returns, though a direct comparison to industry medians is required to assess relative performance. ### Segments and Geographic Exposure Medyssey's revenue is concentrated in spinal implant products, with additional offerings in fixation devices for thoracic and orthopedic surgeries. The company's geographic exposure is primarily within South Korea, with no disclosed international revenue segments. This concentration may limit diversification benefits and increase vulnerability to domestic market fluctuations. ### Growth Trajectory The company's revenue growth trajectory is not explicitly provided, but its strong operating cash flow of KRW 3.46 billion and free cash flow of KRW 1.66 billion suggest a capacity for reinvestment and expansion. The capital expenditure of -KRW 3.04 billion indicates a net outflow, potentially signaling investment in new facilities or equipment. ### Risk Factors The primary risk for Medyssey is liquidity, as highlighted by the negative net cash position after debt. The company's dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. No recent events or filings have been disclosed that would significantly alter the company's risk profile. ### Recent Events No recent events, filings, or transcripts have been disclosed that would significantly impact Medyssey's operations or financial position.
Business. Medyssey Co Ltd is a Korea-based company engaged in the manufacture and sale of orthopedic spinal implants, fixation devices for pectus excavatum, and orthopedic implants for bow-leg correction.
Classification. Medyssey is classified under the Healthcare sector, specifically in the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92.
- Medyssey maintains a strong liquidity position with a current ratio of 5.66.
- The company's ROE of 8.83% and ROA of 7.38% indicate solid profitability.
- The debt-to-equity ratio of 0.06 suggests a conservative capital structure.
- The company's revenue is concentrated in spinal implant products and South Korea.
- The negative net cash position after debt highlights potential liquidity risk.
- No significant dilution risk is identified, with low dilution potential.
- --
- ## RATIONALES
- Net cash is negative after subtracting total debt.